Filter Results:
(398)
Show Results For
- All HBS Web
(398)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (246)
Show Results For
- All HBS Web
(398)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (246)
- January 2006 (Revised May 2007)
- Supplement
Endo Pharmaceuticals (D): Hatch-Waxman Change
By: Richard G. Hamermesh and Brian DeLacey
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (D): Hatch-Waxman Change." Harvard Business School Supplement 806-067, January 2006. (Revised May 2007.)
- January 2006 (Revised May 2007)
- Supplement
Endo Pharmaceuticals (B): Merger Decision
By: Richard G. Hamermesh and Brian DeLacey
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (B): Merger Decision." Harvard Business School Supplement 806-065, January 2006. (Revised May 2007.)
- November 2004 (Revised May 2010)
- Teaching Note
Shurgard Self-Storage: Expansion to Europe and Shurgard Self-Storage: Expansion to Europe (Abridged) (TN)
By: Richard G. Hamermesh and Indra Reinbergs
Keywords: Europe
- June 2001 (Revised April 2003)
- Teaching Note
Kingsley Management TN
By: Richard G. Hamermesh and Michelle Lutz
Teaching Note for (801-474). View Details
- February 2001 (Revised May 2001)
- Teaching Note
Balance, Inc. (A) and (B) TN
By: Richard G. Hamermesh and Michele Lutz
Teaching Note for (9-801-169) and (9-801-170). View Details
- February 2001 (Revised May 2001)
- Case
Balance, Inc. (A)
By: Richard G. Hamermesh and Michele Lutz
Focuses on an entrepreneur who founded a successful health-food store and seeks to expand his retail concept. Illustrates the challenges he faces as he recruits his top management team. View Details
Keywords: Distribution Channels; Executive Compensation; Agreements and Arrangements; Outcome or Result; Recruitment; Management Teams; Selection and Staffing; Food and Beverage Industry
Hamermesh, Richard G., and Michele Lutz. "Balance, Inc. (A)." Harvard Business School Case 801-169, February 2001. (Revised May 2001.)
- January 2001 (Revised May 2001)
- Teaching Note
Return Logic, Inc. (A) and (B) TN
By: Richard G. Hamermesh and Michele Lutz
Teaching Note for (9-801-167) and (9-801-168). View Details
- January 2001 (Revised May 2001)
- Case
Return Logic, Inc. (A)
By: Richard G. Hamermesh and Michele Lutz
Follows three graduating HBS students as they build a business-to-business Internet venture and highlights the challenges they confront in structuring financing terms with venture capitalists. Requires students to carefully read a six-page term sheet to identify which... View Details
Keywords: Venture Capital; Investment Funds; Private Equity; Internet and the Web; Negotiation Deal; Entrepreneurship
Hamermesh, Richard G., and Michele Lutz. "Return Logic, Inc. (A)." Harvard Business School Case 801-167, January 2001. (Revised May 2001.)
- April 1982
- Supplement
General Electric: John F. Welch, Jr., Chairman of the Board, Video
By: Francis Aguilar and Richard G. Hamermesh
Welch discusses a variety of topics. View Details
Keywords: Management Teams; Governing and Advisory Boards; Spoken Communication; Industrial Products Industry
Aguilar, Francis, and Richard G. Hamermesh. "General Electric: John F. Welch, Jr., Chairman of the Board, Video." Harvard Business School Video Supplement 882-524, April 1982.
- 02 Jun 2010
- First Look
First Look: June 2
Lead Times Authors:Santiago Kraiselburd, Richard Pibernik, and Ananth Raman Publication:Production and Operations Management (forthcoming) Abstract It is generally a well acknowledged fact that, ceteris paribus, reducing the lead times... View Details
Keywords: Martha Lagace
- Web
Kraft Accelerator
Hamermesh and Kathy Guisti, plus leaders in the field, including John Wilbanks of Sage Bionetworks, David Shaywitz of Takeda Ventures, Jeff Elton from Concerto Health AI, Wout Brusselaers, Founder & CEO of Deep6, View Details
- January 17, 2022
- Article
Reducing Racial Disparities in Cancer Outcomes
By: Kathy Giusti and Richard G. Hamermesh
A disproportionate number of Black patients die from cancer in the United States. A key to addressing this problem is enrolling more Black patients in clinical trials. A strategy consisting of these three parts can help accomplish this goal: 1) centralize information... View Details
Giusti, Kathy, and Richard G. Hamermesh. "Reducing Racial Disparities in Cancer Outcomes." Harvard Business Review (website) (January 17, 2022).
- August 18, 2020
- Article
What It Takes to Lead a Disease Research Foundation
By: Richard G. Hamermesh and Kathy Giusti
Hamermesh, Richard G., and Kathy Giusti. "What It Takes to Lead a Disease Research Foundation." Harvard Business Review Digital Articles (August 18, 2020).
- 28 Feb 2019
- Interview
Pursuing Precision Medicine at Intermountain Healthcare
By: Richard G. Hamermesh and Brian Kenny
"Pursuing Precision Medicine at Intermountain Healthcare." Cold Call (podcast), Harvard Business Review Group, February 28, 2019.
- June 2015
- Teaching Plan
The National Football League and Brain Injuries
By: Richard G. Hamermesh and Matthew Preble
- May 2012
- Teaching Note
Westlake Lanes: How Can This Business Be Saved? (Brief Case)
By: Richard G. Hamermesh and Alisa Zalosh
- April 2012
- Supplement
Meli Marine, Instructor Supplement (Brief Case)
By: Richard G. Hamermesh and Sunru Yong
- April 2012
- Supplement
Meli Marine, Spreadsheet Supplement (Brief Case)
By: Richard G. Hamermesh and Sunru Yong
- August 2009 (Revised June 2015)
- Case
MINTing Innovation at NewYork-Presbyterian (A)
By: Richard G. Hamermesh and David Kiron
Several top surgeons at NewYork-Presbyterian Hospital (NYP) are receiving financial and administrative support to advance their surgical device inventions through the earliest stages of commercialization. View Details
Keywords: Health Care; Innovation ＆ Entrepreneurship; Hospital; Entrepreneurship; Financing and Loans; Investment; Health Care and Treatment; Innovation and Invention; Intellectual Property; Commercialization; Health Industry; Medical Devices and Supplies Industry; New York (state, US)
Hamermesh, Richard G., and David Kiron. "MINTing Innovation at NewYork-Presbyterian (A)." Harvard Business School Case 810-004, August 2009. (Revised June 2015.)
- January 2006 (Revised May 2007)
- Supplement
Endo Pharmaceuticals (C): An "At Risk" Launch?
By: Richard G. Hamermesh and Brian DeLacey
Hamermesh, Richard G., and Brian DeLacey. Endo Pharmaceuticals (C): An "At Risk" Launch? Harvard Business School Supplement 806-066, January 2006. (Revised May 2007.)